Health Care

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY23 Earnings Concall Transcript

● May 31, 2023

Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Q4 FY23 Earnings Concall dated May. 31, 2023 Corporate Participants: Mayank Vaswani — Investor Relations...

Jubilant Pharmova Q4FY23; Reported Losses

● May 31, 2023

Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101...

Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript

● May 31, 2023

Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Bimal Lalitsingh Goculdas — Chief Executive Officer Analysts:...

Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript

● May 31, 2023

Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 17, 2023. Corporate Participants: Unidentified Speaker — Analysts: Nirav Seksaria — Living Root...

AMI Organics Ltd (AMIORG) Q4 FY23 Earnings Concall Transcript

● May 31, 2023

AMI Organics Ltd (NSE:AMIORG) Q4 FY23 Earnings Concall dated May. 15, 2023. Corporate Participants: Bhavin Shah — Chief Financial Officer Nareshkumar Ramjibhai...

Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY23 Earnings Concall Transcript

● May 31, 2023

Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Hon. Brig. Dr. Arvind Lal — Executive...

Dr. Reddy’s Laboratories (DRREDDY) Q4 FY23 Earnings Concall Transcript

● May 31, 2023

Dr. Reddy’s Laboratories (NSE:DRREDDY) Q4 FY23 Earnings Concall dated May. 10, 2023. Corporate Participants: Richa Periwal — Investor Relations G V Prasad — Co-Chairman...

Vijaya Diagnostics Centre Ltd Q4FY23 results out, revenue grows by 4%

● May 30, 2023

Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include...

Torrent Pharmaceuticals Ltd Q4FY23 revenue grows by 17%

● May 30, 2023

Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting...

Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY23 Earnings Concall Transcript

● May 30, 2023

Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q4 FY23 Earnings Concall dated May. 30, 2023 Corporate Participants: Sudhir Menon — Executive Director, (Finance) and...